Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
Link opens in a new tab
English
Deutsch
Search content at Technical University of Munich
Home
Profiles
Research units
Projects
Research output
Equipment
Prizes
Activities
Press/Media
Graft-versus-leukemia reactions in allogeneic chimeras
Hans Jochem Kolb
, Christoph Schmid
, A. John Barrett
, Dolores J. Schendel
Ludwig-Maximilians-Universität München
Research output
:
Contribution to journal
›
Review article
›
peer-review
371
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Graft-versus-leukemia reactions in allogeneic chimeras'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chimera
100%
Donor Lymphocyte Infusion
100%
Allogeneic
100%
Graft-versus-leukemia Effect
100%
Graft-versus-host Disease (GvHD)
57%
Leukemia
42%
T Cells
28%
Tumor Cells
28%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
28%
Clinical Application
14%
Natural Killer Cells
14%
Hematopoietic Cells
14%
Lymphoma
14%
Adoptive Transfer
14%
Effector Lymphocytes
14%
Effector T Cells
14%
Rapid Progression
14%
Cytolytic Activity
14%
Specific Antigen
14%
Major Complications
14%
Transplantation
14%
Cell Removal
14%
Tumor Growth
14%
Chronic Myeloid Leukemia
14%
Transplant Recipients
14%
Myeloma
14%
HLA Matching
14%
Stem Cell Transplantation
14%
Better Prognosis
14%
Acute Leukemia
14%
Induced Differentiation
14%
Minor Histocompatibility Antigens
14%
Gene-modified T Cells
14%
Myeloid Progenitors
14%
Sustained Remission
14%
Cytokine Stimulation
14%
Suicide Gene
14%
Alloreactive
14%
Alloimmune
14%
Leukemia Relapse
14%
Adoptive Immune Therapy
14%
Costimulatory Molecules
14%
Medicine and Dentistry
Graft Versus Leukemia Effect
100%
Lymphocyte Transfusion
100%
T Cell
57%
Graft Versus Host Reaction
57%
Tumor Cell
28%
Allogeneic Stem Cell Transplantation
28%
Leukemia
28%
Cytokine
14%
Infection
14%
Hematopoietic Cell
14%
Antigen Specificity
14%
Tumor Progression
14%
Adoptive Transfer
14%
Patient with Leukemia
14%
Chronic Myelogenous Leukemia
14%
Myeloma
14%
Stem Cell Transplant
14%
Minor Histocompatibility Antigen
14%
Myeloid Progenitor Cell
14%
Leukemia Relapse
14%
Acute Leukemia
14%
Immunotherapy
14%
Natural Killer Cell
14%
Lymphocyte
14%
Suicide Gene
14%
Immunology and Microbiology
Lymphocyte
100%
Graft-Versus-Host Disease
50%
T Cell
50%
Tumor Cell
25%
Allogeneic Stem Cell Transplantation
25%
Natural Killer Cell
12%
Stem Cell Transplant
12%
Myeloid Progenitor Cell
12%
Antigen Specificity
12%
Immunotherapy
12%
Cytokine
12%
Hematopoietic Cell
12%
Minor Histocompatibility Antigen
12%
Infection
12%
Suicide Gene
12%